2017
The size-reduced Eudragit® RS microparticles prepared by solvent evaporation method – Monitoring the effect of selected variables on tested parameters
VASILEIOU, K.; Jakub VYSLOUŽIL; Miroslava PAVELKOVÁ a Kateřina KUBOVÁZákladní údaje
Originální název
The size-reduced Eudragit® RS microparticles prepared by solvent evaporation method – Monitoring the effect of selected variables on tested parameters
Autoři
Vydání
Ceska a Slovenska Farmacie, Czech Medical Association J.E. Purkyn, 2017, 1210-7816
Další údaje
Typ výsledku
Článek v odborném periodiku
Utajení
není předmětem státního či obchodního tajemství
Označené pro přenos do RIV
Ne
Organizační jednotka
Přírodovědecká fakulta
EID Scopus
Klíčová slova česky
Eudragit RS®; Microparticles; Solvent evaporation; Sustained drug release
Změněno: 5. 5. 2022 17:45, JUDr. Sabina Gajdzioková
Anotace
V originále
Size-reduced microparticles were successfully obtained by solvent evaporation method. Different parameters were applied in each sample and their influence on microparticles was evaluated. As a model drug the insoluble ibuprofen was selected for the encapsulation process with Eudragit® RS. The obtained microparticles were inspected by optical microscopy and scanning electron microscopy. The effect of aqueous phase volume (600, 400, 200 ml) and the concentration of polyvinyl alcohol (PVA; 1.0% and 0.1%) were studied. It was evaluated how those variations and also size can affect microparticle characteristics such as encapsulation efficiency, drug loading, burst effect and microparticle morphology. It was observed that the sample prepared with 600 ml aqueous phase and 1% concentration of polyvinyl alcohol gave the most favorable results.